Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.vineetlabs.co.in | |
Market Cap | 44.25 Cr. | |
Enterprise Value(EV) | 74.34 Cr. | 2022-12 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.07 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 44.97 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 31.87 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 32.54 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 1.47 | Calculated using Price: 48.00 |
Dividend Yield | 2.08 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.92 Cr. | 9,219,008 Shares |
FaceValue | 10 | |
About Vineet Laboratories Ltd. | ||
The company is engaged in the business of Drug Intermediates & Bulk Dugs. |
1 Day |
|
-0.76% |
1 Week |
|
+2.30% |
1 Month |
|
-1.05% |
3 Month |
|
-11.93% |
6 Month |
|
-18.85% |
1 Year |
|
-10.45% |
2 Year |
|
|
5 Year |
|
|
10 Year |
|
5 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -2.87 | 13.18 | 22.19 | |||
Return on Capital Employed (%) | -2.87 | 34.06 | 23.30 | |||
Return on Assets (%) | -2.72 | 3.26 | 5.48 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12* Rs. Cr. |
Shh. Funds | 0 | 0 | 0 | 27 | 33 | 30 | |
Non Curr. Liab. | 7 | 5 | 9 | ||||
Curr. Liab. | 0 | 0 | 75 | 95 | 72 | ||
Minority Int. | |||||||
Equity & Liab. | 0 | 0 | 0 | 109 | 134 | 111 | |
Non Curr. Assets | 22 | 31 | 28 | ||||
Curr. Assets | 0 | 0 | 0 | 86 | 103 | 83 | |
Misc. Exp. not W/O | 0 | 0 | |||||
Total Assets | 0 | 0 | 0 | 109 | 134 | 111 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 243 | 191 | 211 | ||||
Other Income | 0 | 0 | 0 | ||||
Total Income | 244 | 191 | 211 | ||||
Total Expenditure | 0 | -235 | -178 | -203 | |||
PBIDT | 0 | 9 | 14 | 8 | |||
Interest | -3 | -2 | -4 | ||||
Depreciation | -2 | -2 | -2 | ||||
Taxation | -2 | -3 | -1 | ||||
Exceptional Items | |||||||
PAT | 0 | 2 | 7 | 1 | |||
Adjusted EPS | 0 | 2 | 7 | 1 |
Particulars | 5 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 27 | 8 | ||||
Cash Fr. Inv. | -8 | -4 | ||||
Cash Fr. Finan. | 19 | 14 | ||||
Net Change | 38 | 18 | ||||
Cash & Cash Eqvt | 38 | 56 |
Wed, 24 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance Pursuant to Regulation 24A(2) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we are hereby enclosing the Secretarial Compliance Report issued by the Practising Company Secretary for the financial year ended on March 31 2023. |
Thu, 18 May 2023
Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Monday May 29 2023. The purpose of the Board Meeting is - among other matters- to consider and approve the audited financial results of the Company for the 4th quarter and financial year ended on March 31 2023. |
Thu, 20 Apr 2023
Submission Of Compliance Certificate Under Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. The certificate ensuring all activities in relation to Share Transfer Facility are maintained by the Registrar to an issue and share transfer agent - Venture Capital and Corporate Investments Private Limited which is registered with SEBI under registration number: INR000001203. |
Fri, 26 May 2023 |
|
|
|
|
Thu, 25 May 2023 |
|